Thursday, September 19, 2024

Patient Care

Finerenone Meets Primary Endpoint in Phase III Study

Finerenone Meets Primary Endpoint in a Phase III cardiovascular outcomes study, Bayer recently announced the positive results from its Phase III FINEARTS-HF study, which evaluated the efficacy and safety of finerenone in patients with heart failure with mildly reduced...

Latest News

Walmart: History, Growth, Impact, and Future in Global Retail

Introduction Walmart stands as one of the largest and most influential retail corporations in the world. Founded in 1962 by...